...
机译:静脉和口服p受体阻滞对吸入性糖皮质激素控制的持续性哮喘患者的作用
Asthma and Allergy Research Group, Medical Research Institute, University of Dundee, Ninewelis Hospital and Medical School, Dundee, UK;
Asthma and Allergy Research Group, Medical Research Institute, University of Dundee, Ninewelis Hospital and Medical School, Dundee, UK;
Asthma and Allergy Research Group, Medical Research Institute, University of Dundee, Ninewelis Hospital and Medical School, Dundee, UK;
Asthma and Allergy Research Group, Medical Research Institute, University of Dundee, Ninewelis Hospital and Medical School, Dundee DD1 9SY, UK;
机译:吸入皮质类固醇和短期皮质类固醇激素对哮喘患者骨矿物质密度的影响:一项为期4年的纵向研究
机译:口服和糖皮质激素对6至15岁儿童中度持续性哮喘的安全性和有效性:一项随机对照试验
机译:布地奈德/福莫特罗pMDI与氟替卡松/沙美特罗DPI和沙丁胺醇pMDI相比,其早期支气管扩张作用:两项先前接受吸入糖皮质激素治疗的持续性哮喘成人的随机对照试验。
机译:系统皮质类固醇处理可降低Cortlcosterollold敏感的活化剂蛋白-1(AP-1)组分的支气管粘膜活化,但不能抵抗哮喘
机译:哮喘患者的吸入器设备,给药技术和对吸入性糖皮质激素的依从性。
机译:口服和吸入糖皮质激素对哮喘患者淋巴细胞β2-肾上腺素受体功能的影响
机译:口服和吸入糖皮质激素对哮喘患者淋巴细胞β2-肾上腺素受体功能的影响
机译:静脉注射喜树碱Na盐(Nsc-100 880)对犬和猴的毒性作用。静脉和口服给药对小鼠的毒性作用